Greek industry boss: are we going to increase public pharmaceutical expenditure?

8 April 2019
greece_greek_big

The president of Greek industry association the Hellenic Association of Pharmaceutical Companies (SFEE) painted an alarming picture on the current and future state of Greek healthcare at the group’s general assembly meeting.

Olympios Papadimitriou spoke about the negative impact of austerity on the healthcare sector, and about the need for action now that Greek faces an increasing demographic crisis.

"Per capita expenditure for medicinal products and other health-related consumables follows a downward spiral"He said: “The period of the economic crisis left indelible marks on the healthcare sector. For example, the public per capita expenditure for medicinal products and other health-related consumables in Greece follows a downward spiral and is now below the European average and below the average of the countries in the south of Europe.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical